GLP-1 Receptor Agonist Weight Loss Medication Side Effects: Understanding the Risks and Benefits
GLP-1 receptor agonists, also known as GLP-1 agonists, are a class of medications that have revolutionized the treatment of obesity and type 2 diabetes. These medications work by mimicking the natural hormone glucagon-like peptide-1 (GLP-1), which regulates blood sugar, digestion, and hunger. However, like any medication, GLP-1 agonists come with side effects that patients should be aware of.
Common Side Effects of GLP-1 Receptor Agonist Weight Loss Medication
The most common side effects of GLP-1 agonists include nausea, vomiting, constipation, and diarrhea, which occur in up to 40% of people taking these medications. Other common side effects include:
- Nausea and vomiting
- Constipation and diarrhea
- Abdominal pain and discomfort
- Headaches and dizziness
- Fatigue and weakness
Some GLP-1 agonists, such as semaglutide (Ozempic and Wegovy), may also cause more severe side effects, including:
- Skin sagging and wrinkles, known as "Ozempic face"
- Increased risk of pancreatitis
- Increased risk of thyroid cancer
- Increased risk of gallbladder disease
Less Common Side Effects of GLP-1 Receptor Agonist Weight Loss Medication
Less common side effects of GLP-1 agonists include:
- Clinical depression and anxiety
- Renal failure and acute kidney injury
- Thyroid dysfunction
- Blood glucose imbalances
- Increased risk of hypoglycemia
